Three is better than one: Pre-ligand receptor assembly in the regulation of TNF receptor signaling

Cytokine

Volumn 37, Issue 2, 2007, Pages 101-107

  Chan, Francis Ka Ming ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; PLAD; Pre ligand assembly domain; TNF; TRAIL

Indexed keywords

LIGAND; OLIGOMER; TUMOR NECROSIS FACTOR RECEPTOR;

BINDING AFFINITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SURFACE; DOWNSTREAM PROCESSING; HUMAN; IMMUNE SYSTEM; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW;

ANIMALS; ANTIGENS, CD95; HUMANS; LIGANDS; PROTEIN STRUCTURE, QUATERNARY; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

METAZOA;

EID: 34247899117     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2007.03.005     Document Type: Review

References (58)

1. Schlessinger J. Common and distinct elements in cellular signaling via EGF and FGF receptors. Science 306 (2004) 1506-1507
2. Ozcan F., Klein P., Lemmon M.A., Lax I., and Schlessinger J. On the nature of low- and high-affinity EGF receptors on living cells. Proc Natl Acad Sci USA 103 (2006) 5735-5740
3. Leonard W.J. Cytokines and immunodeficiency diseases. Nat Rev Immunol 1 (2001) 200-208
4. Chan F.K., Siegel M.R., and Lenardo J.M. Signaling by the TNF receptor superfamily and T cell homeostasis. Immunity 13 (2000) 419-422
5. Locksley R.M., Killeen N., and Lenardo M.J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104 (2001) 487-501
6. Banner D.W., D'Arcy A., Janes W., Gentz R., Schoenfeld H.J., Broger C., et al. Crystal structure of the soluble human 55 kDa TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell 73 (1993) 431-445
7. Cha S.S., Sung B.J., Kim Y.A., Song Y.L., Kim H.J., Kim S., et al. Crystal structure of TRAIL-DR5 complex identifies a critical role of the unique frame insertion in conferring recognition specificity. J Biol Chem 275 (2000) 31171-31177
8. Hymowitz S.G., Christinger H.W., Fuh G., Ultsch M., O'Connell M., Kelley R.F., et al. Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5. Mol Cell 4 (1999) 563-571
9. Mongkolsapaya J., Grimes J.M., Chen N., Xu X.N., Stuart D.I., Jones E.Y., et al. Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation. Nat Struct Biol 6 (1999) 1048-1053
10. Boldin M.P., Mett I.L., Varfolomeev E.E., Chumakov I., Shemer-Avni Y., Camonis J.H., et al. Self-association of the "death domains" of the p55 tumor necrosis factor (TNF) receptor and Fas/APO1 prompts signaling for TNF and Fas/APO1 effects. J Biol Chem 270 (1995) 387-391
11. Heller R.A., Song K., Fan N., and Chang D.J. The p70 tumor necrosis factor receptor mediates cytotoxicity. Cell 70 (1992) 47-56
12. Haridas V., Darnay B.G., Natarajan K., Heller R., and Aggarwal B.B. Overexpression of the p80 TNF receptor leads to TNF-dependent apoptosis, nuclear factor-kappa B activation, and c-Jun kinase activation. J Immunol 160 (1998) 3152-3162
13. Weiss T., Grell M., Siemienski K., Muhlenbeck F., Durkop H., Pfizenmaier K., et al. TNFR80-dependent enhancement of TNFR60-induced cell death is mediated by TNFR-associated factor 2 and is specific for TNFR60. J Immunol 161 (1998) 3136-3142
14. Declercq W., Denecker G., Fiers W., and Vandenabeele P. Cooperation of both TNF receptors in inducing apoptosis: involvement of the TNF receptor-associated factor binding domain of the TNF receptor 75. J Immunol 161 (1998) 390-399
15. Chan F.K., and Lenardo M.J. A crucial role for p80 TNF-R2 in amplifying p60 TNF-R1 apoptosis signals in T lymphocytes. Eur J Immunol 30 (2000) 652-660
16. Chan F.K., Shisler J., Bixby J.G., Felices M., Zheng L., Appel M., et al. A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses. J Biol Chem 278 (2003) 51613-51621
17. Rao V.K., and Straus S.E. Causes and consequences of the autoimmune lymphoproliferative syndrome. Hematology 11 (2006) 15-23
18. Siegel R.M., Chan F.K., Chun H.J., and Lenardo M.J. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat Immunol 1 (2000) 469-474
19. Siegel R.M., Frederiksen J.K., Zacharias D.A., Chan F.K., Johnson M., Lynch D., et al. Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science 288 (2000) 2354-2357
20. Chan F.K., Chun H.J., Zheng L., Siegel R.M., Bui K.L., and Lenardo M.J. A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science 288 (2000) 2351-2354
21. Papoff G., Hausler P., Eramo A., Pagano M.G., Di Leve G., Signore A., et al. Identification and characterization of a ligand-independent oligomerization domain in the extracellular region of the CD95 death receptor. J Biol Chem 274 (1999) 38241-38250
22. Naismith J.H., Brandhuber B.J., Devine T.Q., and Sprang S.R. Seeing double: crystal structures of the type I TNF receptor. J Mol Recognit 9 (1996) 113-117
23. Naismith J.H., Devine T.Q., Brandhuber B.J., and Sprang S.R. Crystallographic evidence for dimerization of unliganded tumor necrosis factor receptor. J Biol Chem 270 (1995) 13303-13307
24. Naismith J.H., Devine T.Q., Kohno T., and Sprang S.R. Structures of the extracellular domain of the type I tumor necrosis factor receptor. Structure 4 (1996) 1251-1262
25. Chan F.K., Siegel R.M., Zacharias D., Swofford R., Holmes K.L., Tsien R.Y., et al. Fluorescence resonance energy transfer analysis of cell surface receptor interactions and signaling using spectral variants of the green fluorescent protein. Cytometry 44 (2001) 361-368
26. Clancy L., Mruk K., Archer K., Woelfel M., Mongkolsapaya J., Screaton G., et al. Preligand assembly domain-mediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosis. Proc Natl Acad Sci USA 102 (2005) 18099-18104
27. Sedger L.M., Osvath S.R., Xu X.M., Li G., Chan F.K., Barrett J.W., et al. Poxvirus tumor necrosis factor receptor (TNFR)-like T2 proteins contain a conserved preligand assembly domain that inhibits cellular TNFR1-induced cell death. J Virol 80 (2006) 9300-9309
28. Gordon N.C., Pan B., Hymowitz S.G., Yin J., Kelley R.F., Cochran A.G., et al. BAFF/BLyS receptor 3 comprises a minimal TNF receptor-like module that encodes a highly focused ligand-binding site. Biochemistry 42 (2003) 5977-5983
29. Huang B., Eberstadt M., Olejniczak E.T., Meadows R.P., and Fesik S.W. NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain. Nature 384 (1996) 638-641
30. Martin D.A., Zheng L., Siegel R.M., Huang B., Fisher G.H., Wang J., et al. Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia. Proc Natl Acad Sci USA 96 (1999) 4552-4557
31. Park Y.C., Burkitt V., Villa A.R., Tong L., and Wu H. Structural basis for self-association and receptor recognition of human TRAF2. Nature 398 (1999) 533-538
32. Ye H., Park Y.C., Kreishman M., Kieff E., and Wu H. The structural basis for the recognition of diverse receptor sequences by TRAF2. Mol Cell 4 (1999) 321-330
33. McWhirter S.M., Pullen S.S., Holton J.M., Crute J.J., Kehry M.R., and Alber T. Crystallographic analysis of CD40 recognition and signaling by human TRAF2. Proc Natl Acad Sci USA 96 (1999) 8408-8413
34. Park Y.C., Ye H., Hsia C., Segal D., Rich R.L., Liou H.C., et al. A novel mechanism of TRAF signaling revealed by structural and functional analyses of the TRADD-TRAF2 interaction. Cell 101 (2000) 777-787
35. Siegel R.M., Muppidi J.R., Sarker M., Lobito A., Jen M., Martin D., et al. SPOTS: signaling protein oligomeric transduction structures are early mediators of death receptor-induced apoptosis at the plasma membrane. J Cell Biol 167 (2004) 735-744
36. Feig C., Tchikov V., Schutze S., and Peter M.E. Palmitoylation of CD95 facilitates formation of SDS-stable receptor aggregates that initiate apoptosis signaling. EMBO J 26 (2007) 221-231
37. Jiang Y., Woronicz J.D., Liu W., and Goeddel D.V. Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. Science 283 (1999) 543-546
38. Budd R.C., Yeh W.C., and Tschopp J. cFLIP regulation of lymphocyte activation and development. Nat Rev Immunol 6 (2006) 196-204
39. Peter M.E., Kischkel F.C., Scheuerpflug C.G., Medema J.P., Debatin K.M., and Krammer P.H. Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/caspase 8) to the CD95 death-inducing signaling complex. Eur J Immunol 27 (1997) 1207-1212
40. Zheng L., Fisher G., Miller R.E., Peschon J., Lynch D.H., and Lenardo M.J. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377 (1995) 348-351
41. Muppidi J.R., and Siegel R.M. Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death. Nat Immunol 5 (2004) 182-189
42. Hornung F., Zheng L., and Lenardo M.J. Maintenance of clonotype specificity in CD95/Apo-1/Fas-mediated apoptosis of mature T lymphocytes. J Immunol 159 (1997) 3816-3822
43. Combadiere B., Reis e Sousa C., Trageser C., Zheng L.X., Kim C.R., and Lenardo M.J. Differential TCR signaling regulates apoptosis and immunopathology during antigen responses in vivo. Immunity 9 (1998) 305-313
44. Lenardo M., Chan K.M., Hornung F., McFarland H., Siegel R., Wang J., et al. Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment. Annu Rev Immunol 17 (1999) 221-253
45. Almasan A., and Ashkenazi A. Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy. Cytokine Growth Factor Rev 14 (2003) 337-348
46. Lee H.W., Lee S.H., Lee H.W., Ryu Y.W., Kwon M.H., and Kim Y.S. Homomeric and heteromeric interactions of the extracellular domains of death receptors and death decoy receptors. Biochem Biophys Res Commun 330 (2005) 1205-1212
47. Hamilton S.E., Wolkers M.C., Schoenberger S.P., and Jameson S.C. The generation of protective memory-like CD8(+) T cells during homeostatic proliferation requires CD4(+) T cells. Nat Immunol 7 (2006) 475-481
48. Janssen E.M., Droin N.M., Lemmens E.E., Pinkoski M.J., Bensinger S.J., Ehst B.D., et al. CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death. Nature 434 (2005) 88-93
49. Hilliard B., Wilmen A., Seidel C., Liu T.S., Goke R., and Chen Y. Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis. J Immunol 166 (2001) 1314-1319
50. Lamhamedi-Cherradi S.E., Zheng S., Tisch R.M., and Chen Y.H. Critical roles of tumor necrosis factor-related apoptosis-inducing ligand in type 1 diabetes. Diabetes 52 (2003) 2274-2278
51. Lamhamedi-Cherradi S.E., Zheng S.J., Maguschak K.A., Peschon J., and Chen Y.H. Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/- mice. Nat Immunol 4 (2003) 255-260
52. Mi Q.S., Ly D., Lamhamedi-Cherradi S.E., Salojin K.V., Zhou L., Grattan M., et al. Blockade of tumor necrosis factor-related apoptosis-inducing ligand exacerbates type 1 diabetes in NOD mice. Diabetes 52 (2003) 1967-1975
53. Song K., Chen Y., Goke R., Wilmen A., Seidel C., Goke A., et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression. J Exp Med 191 (2000) 1095-1104
54. Cretney E., McQualter J.L., Kayagaki N., Yagita H., Bernard C.C., Grewal I.S., et al. TNF-related apoptosis-inducing ligand (TRAIL)/Apo2L suppresses experimental autoimmune encephalomyelitis in mice. Immunol Cell Biol 83 (2005) 511-519
55. Benedict C.A., Norris P.S., and Ware C.F. To kill or be killed: viral evasion of apoptosis. Nat Immunol 3 (2002) 1013-1018
56. Macen J.L., Graham K.A., Lee S.F., Schreiber M., Boshkov L.K., and McFadden G. Expression of the myxoma virus tumor necrosis factor receptor homologue and M11L genes is required to prevent virus-induced apoptosis in infected rabbit T lymphocytes. Virology 218 (1996) 232-237
57. Chan F.K. The pre-ligand binding assembly domain: a potential target of inhibition of tumour necrosis factor receptor function. Ann Rheum Dis 59 Suppl 1 (2000) i50-i53
58. Deng G.M., Zheng L., Chan F.K., and Lenardo M. Amelioration of inflammatory arthritis by targeting the pre-ligand assembly domain of tumor necrosis factor receptors. Nat Med 11 (2005) 1066-1072